Search

Online Programs

Sort by Expiration Date :

Evolving Evidence in the Management of Patients with Non-Small Cell Lung Cancer: Clinical Pearls for the Community Practitioner

This educational activity will feature an expert-led discussion about key clinical data surrounding the use of immune checkpoint inhibitors (ICIs), both as monotherapy and in combination with chemotherapy, to manage patients with advanced non-small cell lung cancer (NSCLC) without actional genomic alterations. In addition to covering data surrounding clinical efficacy of ICIs, expert faculty will also describe immune-related adverse events that must be monitored for and mitigated as they arise.

RELEASED DATE: October 31, 2024
EXPIRATION DATE: October 31, 2025

Learn More & View Event »

Evolving Evidence in the Management of Patients with Non-Small Cell Lung Cancer: Clinical Pearls for the Community Practitioner

This interactive enduring activity is designed to educate healthcare professionals on the evidence-based implementation of immune checkpoint inhibitors into the management of patients with non-small cell lung cancer (NSCLC). A special emphasis will be placed on how to optimize care across a multidisciplinary and community-based oncology care team, using a patient-centered approach augmented by shared decision-making practices.

RELEASED DATE: December 20, 2024
EXPIRATION DATE: December 20, 2025

Learn More & View Event »

Scientific Council

Neil M. Bressler, MD

James P. Gills Professor of Ophthalmology
Professor of Ophthalmology, Johns Hopkins University School of Medicine
Wilmer Eye Institute, Johns Hopkins Medicine
Baltimore, MD

A. Paul Chous, MA, OD, FAAO

Specializing in Diabetes Eye Care & Education, Chous Eye Care Associates
Adjunct Professor of Optometry, Western University of Health Sciences
AOA Representative, National Diabetes Education Program
Tacoma, WA

Steven Ferrucci, OD, FAAO

Chief of Optometry, Sepulveda VA Medical Center
Professor, Southern California College of Optometry at Marshall B. Ketchum University
Sepulveda, CA

Julia A. Haller, MD

Ophthalmologist-in-Chief
Wills Eye Hospital
Philadelphia, PA

Allen C. Ho, MD, FACS

Director, Retina Research
Wills Eye Hospital
Professor and Chair of the Department of Ophthalmology
Thomas Jefferson University Hospitals
Philadelphia, PA

Charles C. Wykoff, MD, PhD

Director of Research, Retina Consultants of Houston
Associate Professor of Clinical Ophthalmology
Blanton Eye Institute & Houston Methodist Hospital
Houston, TX

Search

[divi_global_search_form]

Clinician Scientific & Educational Resources

The RELIEF Clinical Toolkit is an online tool that aims to provide clinicians with up-to-date information on the presentation, prognosis, pathophysiology, and treatment strategies for retinopathy of prematurity (ROP). Click on one of the options below to learn more about ROP.

Patient Toolkit

Patient Toolkit

Read more

What exactly is NSCLC?

What exactly is NSCLC?

Read more

What symptoms can NSCLC cause?

What symptoms can NSCLC cause?

Read more

How is NSCLC treated according to staging?

How is NSCLC treated according to staging?

Read more

How is early NSCLC treated with surgery or SBRT?

How is early NSCLC treated with surgery or SBRT?

Read more

When is chemotherapy used in NSCLC?

When is chemotherapy used in NSCLC?

Read more

When is radiation used in NSCLC?

When is radiation used in NSCLC?

Read more

When is immunotherapy used in NSCLC?

When is immunotherapy used in NSCLC?

Read more

When is targeted therapy used in NSCLC?

When is targeted therapy used in NSCLC?

Read more

Online resources

Online resources

Read more
This activity is provided by Med Learning Group. This activity is co-provided by Ultimate Medical Academy/Complete Conference Management (CCM). This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Copyright © 2019 | ROP Relief | All Rights Reserved | Website by Divigner